pipette
ENEnglish

Altered herpesvirus-specific immune response is associated with long COVID

R. V. Joshi, R. M. Khan, K. J. Jackson, S. Ballouz, B. Jacka, L. Ni, N. Findell-Aghnatios, A. Aggarwal, S. G. Turville, M. Singh, K. W. Kim, C. Yau, A. Byrne, B. J. Brew, G. J. Dore, D. R. Darley, G. V. Matthews, A. D. Kelleher, C. Phetsouphanh

Preprint

En palabras de los autores

Long COVID is associated with persistent immune dysregulation, but whether immunity to latent viruses is also altered remains unclear. We profiled herpesvirus-specific antibodies and T-cell responses in people with long COVID and recovered convalescent controls at 4, 8, and 24 months after SAR-CoV-2 infection. Overall antibody reactivity and abundance against cytomegalovirus (CMV) and Epstein-Barr virus (EBV) responder frequencies and circulating B-cell subsets were broadly preserved, but early antibody avidity and virus-specific CD4 T cell response magnitude were reduced. Neither virus nucleic acid was detected in plasma or stool at 4 or 8 months. Here, we show that long COVID is associated with selective, time-dependent alteration of herpesvirus-specific immune memory, including relatively preserved or enhanced CD8 responses and greater representation of selected herpesvirus-associated T-cell receptor clonotypes. Together, these findings indicate altered herpesvirus-specific antibody quality despite broadly preserved antibody abundance. Lower EBV avidity was associated with poorer quality of life and unrecovered status.

Resultado principalEl resumen no menciona limitaciones.

Apareció: viernes, 13 de noviembre. medRxiv. Preprint, todavía sin revisión por pares.

DOI: 10.64898/2026.11.11.26367525